The global medicated skincare market size is calculated at USD 48.38 billion in 2025 and is forecasted to reach around USD 77.66 billion by 2034, accelerating at a CAGR of 5.40% from 2025 to 2034. The North America market size surpassed USD 15.61 billion in 2024 and is expanding at a CAGR of 5.54% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Medicated Skincare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Medicated Skincare Market Revenue and Volume Forecast, by Skin Condition
8.1.1. Acne
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Psoriasis
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Eczema
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Rosacea
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Others
8.1.5.1. Market Revenue and Volume Forecast
9.1. Medicated Skincare Market Revenue and Volume Forecast, by Ingredient
9.1.1. Anti-inflammatories
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Antibacterials
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Antifungals
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Antioxidants
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Moisturizers
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Synthetic ingredients
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Natural/organic ingredients
9.1.7.1. Market Revenue and Volume Forecast
9.1.8. Chemical-based ingredients
9.1.7.1. Market Revenue and Volume Forecast
10.1. Medicated Skincare Market Revenue and Volume Forecast, by Application
10.1.1. Creams
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Lotions
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Ointments
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Gels
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Serums
10.1.5.1. Market Revenue and Volume Forecast
11.1. Medicated Skincare Market Revenue and Volume Forecast, by Distribution Channel
11.1.1. Dermatology Clinics
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Online Pharmacies
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Retail Pharmacies
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Skin Condition
12.1.2. Market Revenue and Volume Forecast, by Ingredient
12.1.3. Market Revenue and Volume Forecast, by Application
12.1.4. Market Revenue and Volume Forecast, by Distribution Channel
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Skin Condition
12.1.5.2. Market Revenue and Volume Forecast, by Ingredient
12.1.5.3. Market Revenue and Volume Forecast, by Application
12.1.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Skin Condition
12.1.6.2. Market Revenue and Volume Forecast, by Ingredient
12.1.6.3. Market Revenue and Volume Forecast, by Application
12.1.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Skin Condition
12.2.2. Market Revenue and Volume Forecast, by Ingredient
12.2.3. Market Revenue and Volume Forecast, by Application
12.2.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Skin Condition
12.2.5.2. Market Revenue and Volume Forecast, by Ingredient
12.2.5.3. Market Revenue and Volume Forecast, by Application
12.2.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Skin Condition
12.2.6.2. Market Revenue and Volume Forecast, by Ingredient
12.2.6.3. Market Revenue and Volume Forecast, by Application
12.2.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Skin Condition
12.2.7.2. Market Revenue and Volume Forecast, by Ingredient
12.2.7.3. Market Revenue and Volume Forecast, by Application
12.2.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Skin Condition
12.2.8.2. Market Revenue and Volume Forecast, by Ingredient
12.2.8.3. Market Revenue and Volume Forecast, by Application
12.2.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Skin Condition
12.3.2. Market Revenue and Volume Forecast, by Ingredient
12.3.3. Market Revenue and Volume Forecast, by Application
12.3.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Skin Condition
12.3.5.2. Market Revenue and Volume Forecast, by Ingredient
12.3.5.3. Market Revenue and Volume Forecast, by Application
12.3.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Skin Condition
12.3.6.2. Market Revenue and Volume Forecast, by Ingredient
12.3.6.3. Market Revenue and Volume Forecast, by Application
12.3.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Skin Condition
12.3.7.2. Market Revenue and Volume Forecast, by Ingredient
12.3.7.3. Market Revenue and Volume Forecast, by Application
12.3.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Skin Condition
12.3.8.2. Market Revenue and Volume Forecast, by Ingredient
12.3.8.3. Market Revenue and Volume Forecast, by Application
12.3.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Skin Condition
12.4.2. Market Revenue and Volume Forecast, by Ingredient
12.4.3. Market Revenue and Volume Forecast, by Application
12.4.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Skin Condition
12.4.5.2. Market Revenue and Volume Forecast, by Ingredient
12.4.5.3. Market Revenue and Volume Forecast, by Application
12.4.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Skin Condition
12.4.6.2. Market Revenue and Volume Forecast, by Ingredient
12.4.6.3. Market Revenue and Volume Forecast, by Application
12.4.6.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Skin Condition
12.4.7.2. Market Revenue and Volume Forecast, by Ingredient
12.4.7.3. Market Revenue and Volume Forecast, by Application
12.4.7.4. Market Revenue and Volume Forecast, by Distribution Channel
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Skin Condition
12.4.8.2. Market Revenue and Volume Forecast, by Ingredient
12.4.8.3. Market Revenue and Volume Forecast, by Application
12.4.8.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Skin Condition
12.5.2. Market Revenue and Volume Forecast, by Ingredient
12.5.3. Market Revenue and Volume Forecast, by Application
12.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Skin Condition
12.5.5.2. Market Revenue and Volume Forecast, by Ingredient
12.5.5.3. Market Revenue and Volume Forecast, by Application
12.5.5.4. Market Revenue and Volume Forecast, by Distribution Channel
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Skin Condition
12.5.6.2. Market Revenue and Volume Forecast, by Ingredient
12.5.6.3. Market Revenue and Volume Forecast, by Application
12.5.6.4. Market Revenue and Volume Forecast, by Distribution Channel
13.1. Galderma Laboratories
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Johnson & Johnson
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. L’Oréal S.A.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Beiersdorf AG
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Procter & Gamble Co.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Unilever Plc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Neocutis
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. SkinCeuticals
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Obagi Medical
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Dermalogica
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample